Filip Zemek - Search Results

Year	Number of Results
2010	4
2011	5
2012	3
2013	5
2014	1
2016	1
2020	1
2022	0

1

Albumin and α1-acid glycoprotein: old acquaintances.

Filip Z, Jan K, Vendula S, Jana KZ, Kamil M, Kamil K. Filip Z, et al. Expert Opin Drug Metab Toxicol. 2013 Aug;9(8):943-54. doi: 10.1517/17425255.2013.790364. Epub 2013 Apr 26. Expert Opin Drug Metab Toxicol. 2013. PMID: 23621565 Review.

2

Adamantane - A Lead Structure for Drugs in Clinical Practice.

Spilovska K, Zemek F, Korabecny J, Nepovimova E, Soukup O, Windisch M, Kuca K. Spilovska K, et al. Among authors: zemek f. Curr Med Chem. 2016;23(29):3245-3266. doi: 10.2174/0929867323666160525114026. Curr Med Chem. 2016. PMID: 27222266 Review.

3

Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine.

Zemek F, Drtinova L, Nepovimova E, Sepsova V, Korabecny J, Klimes J, Kuca K. Zemek F, et al. Expert Opin Drug Saf. 2014 Jun;13(6):759-74. doi: 10.1517/14740338.2014.914168. Expert Opin Drug Saf. 2014. PMID: 24845946 Review.

4

[Intended pharmacotherapeutical approaches of Alzheimer's disease therapy].

Korábecný J, Hrubá E, Soukup O, Zemek F, Musílek K, Nepovímová E, Spilovská K, Opletalová V, Kuca K. Korábecný J, et al. Among authors: zemek f. Ceska Slov Farm. 2012 Feb;61(1-2):4-10. Ceska Slov Farm. 2012. PMID: 22536646 Review. Czech.

5

Anticipated Social and Healthcare Economic Burden of People with Alzheimer's Disease in Two Selected Regions of the Czech Republic.

Maresova P, Komarkova L, Kuhnova J, Cimler R, Pazitny P, Kandilaki D, Musilek K, Truhlarova Z, Zemek F, Kuca K. Maresova P, et al. Among authors: zemek f. Healthcare (Basel). 2020 Oct 26;8(4):433. doi: 10.3390/healthcare8040433. Healthcare (Basel). 2020. PMID: 33114626 Free PMC article.

6

Oximes: inhibitors of human recombinant acetylcholinesterase. A structure-activity relationship (SAR) study.

Sepsova V, Karasova JZ, Korabecny J, Dolezal R, Zemek F, Bennion BJ, Kuca K. Sepsova V, et al. Among authors: zemek f. Int J Mol Sci. 2013 Aug 16;14(8):16882-900. doi: 10.3390/ijms140816882. Int J Mol Sci. 2013. PMID: 23959117 Free PMC article.

7

Passive diffusion of acetylcholinesterase oxime reactivators through the blood-brain barrier: influence of molecular structure.

Karasova JZ, Pohanka M, Musilek K, Zemek F, Kuca K. Karasova JZ, et al. Among authors: zemek f. Toxicol In Vitro. 2010 Sep;24(6):1838-44. doi: 10.1016/j.tiv.2010.05.009. Epub 2010 May 26. Toxicol In Vitro. 2010. PMID: 20546883

8

Toxicological scoring of Alzheimer's disease drug huperzine in a guinea pig model.

Pohanka M, Zemek F, Bandouchova H, Pikula J. Pohanka M, et al. Among authors: zemek f. Toxicol Mech Methods. 2012 Apr;22(3):231-5. doi: 10.3109/15376516.2011.635320. Epub 2011 Nov 23. Toxicol Mech Methods. 2012. PMID: 22112162

9

Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.

Korabecny J, Musilek K, Holas O, Binder J, Zemek F, Marek J, Pohanka M, Opletalova V, Dohnal V, Kuca K. Korabecny J, et al. Among authors: zemek f. Bioorg Med Chem Lett. 2010 Oct 15;20(20):6093-5. doi: 10.1016/j.bmcl.2010.08.044. Epub 2010 Aug 16. Bioorg Med Chem Lett. 2010. PMID: 20817518

10

Huperzine induces alteration in oxidative balance and antioxidants in a guinea pig model.

Pohanka M, Hrabinova M, Zemek F, Drtinova L, Bandouchova H, Pikula J. Pohanka M, et al. Among authors: zemek f. Neuro Endocrinol Lett. 2011;32 Suppl 1:95-100. Neuro Endocrinol Lett. 2011. PMID: 22167216

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results